Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{195768,
        author = {Balraj Sharma and Mrs. Vasudha and Yoshita Sood and Phanindrareddy Badduri and Rachna Chavda},
        title = {Exploring Ketamine as a Treatment Option for Psychiatric Disorders},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {11},
        pages = {1324-1332},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=195768},
        abstract = {Pain Ketamine has emerged as a significant new alternative in the treatment of inappropriate mental health disorders like depression, anxiety, and post-traumatic stress disorder. Due to the ongoing rise in mental illnesses across the globe and inability to ameliorate some mental illnesses by means of standard drug medications, ketamine represents a potential option due to its special mode of action. Ketamine, firstly, was approved by the U.S. Food and Drug Administration in 1970 as an anesthetic drug, but in the past two decades has found more and more applications as an off-label treatment of psychiatric conditions. Moreover, esketamine, the S-ketamine derivative that is sold as Spravato, was approved in 2019 to treat resistant depression.
The application of ketamine in mental health care nowadays takes various forms, such as intranasal ketamine, intravenous infusion, ketamine-aided psychotherapy, and home-based therapy, featuring greater or lesser levels of monitoring and supervision. The current situation with the ketamine treatment is complicated due to the lack of regulation, persisting development of research evidence, and drug need by numerous patients with treatment-resistant mental health symptoms. To discuss these problems, this article will provide the necessary clinical knowledge that nurses are expected to possess in conversations with patients when guiding them on ketamine usage or as an option of treatment. It additionally points out regulatory, ethical, and nursing-related elements of using ketamine in treating the mental illnesses.},
        keywords = {— anxiety, depression, ketamine, mental health, posttraumatic stress disorder.},
        month = {April},
        }